Possible roles of neuropeptide Y Y3-receptor subtype in rat aortic endothelial cell proliferation under hypoxia, and its specific signal transduction

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 293, Issue 2, 2007, Pages

  Chen, Zhi Yong ^b   Feng, Guo Gang ^a   Nishiwaki, Kimitoshi ^b   Shimada, Yasuhiro ^b   Fujiwara, Yoshihiro ^a   Komatsu, Toru ^a   Ishikawa, Naohisa ^a  

^a AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Calmodulin dependent protein kinase; Phosphatidylinositol 3 kinase; Phospholipase C; Protein kinase C

Indexed keywords

1 (5 CHLORO 1 NAPHTHALENESULFONYL)HEXAHYDRO 1H 1,4 DIAZEPINE; 1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; IMATINIB; NEUROPEPTIDE Y3 RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE C; RECEPTOR SUBTYPE;

ANIMAL CELL; AORTA; ARTICLE; CELL COUNT; CELL HYPOXIA; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; AORTA; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CALCIUM; CALMODULIN; CASPASE 3; CELL HYPOXIA; CELL MEMBRANE PERMEABILITY; CELL PROLIFERATION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; ENZYME INHIBITORS; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; MALE; NEUROPEPTIDE Y; PEPTIDE FRAGMENTS; PEPTIDE YY; PHOSPHOLIPASE C; RATS; RATS, WISTAR; RECEPTORS, NEUROPEPTIDE; SIGNAL TRANSDUCTION;

EID: 34547895112     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00886.2006     Document Type: Article

References (35)

1. (3-36) physiologically inhibits food intake. Nature 418: 650-654, 2002.
2. Ben-Yosef Y, Miller A, Shapiro S, Lahat N. Hypoxia of endothelial cells leads to MMP-2-dependent survival and death. Am J Physiol Cell Physiol 289: C1321-C1331, 2005.
3. Casciola-Rosen L, Nicholson DW, Chong T, Rowan KR, Thornberry NA, Miller DK, Rosen A. Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death. J Exp Med 183: 1957-1964, 1996.
4. Clermont AC, Cahill M, Salti H, Rook SL, Rask Madsen C, Giddard L, Wong JS, Bursell D, Bursell SE, Aiello LP. Hepatocyte growth factor induces retinal vascular permeability via MAP-kinase and PI-3 kinase without altering retinal hemodynamics. Invest Ophthalmol Vis Sci 47: 2701-2708, 2006.
5. Cohen GM. Caspases: the executioners of apoptosis. Biochem J 326: 1-16, 1997.
6. Eelinge D, Brunkwall J, Edvinsson L. Neuropeptide Y stimulates proliferation of human vascular smooth muscle cells: cooperation with noradrenaline and ATP. Regul Pept 50: 259-265, 1994.
7. Feliers D, Chen X, Akis N, Choudhury GG, Madaio M, Kasinath BS. VEGF regulation of endothelial nitric oxide synthase in glomerular endothelial cells. Kidney Int 68: 1648-1659, 2005.
8. Fu JR, Liu WL, Zou JF, Sun HY, Xu HZ, Luo L, Zhang H, Zhou YF. Sonic hedgehog protein promotes bone marrow-derived endothelial progenitor cell proliferation, migration and VEGF production via PI 3-kinase/ Akt signaling pathways. Acta Pharmacol Sin 27: 685-693, 2006.
9. Gray TS, Morley JE. Neuropeptide Y: anatomical distribution and possible function in the mammalian nervous system. Life Sci 38: 389-401, 1986.
10. Haegerstrand A, Dalsgaard C, Jonzon B, Larsson O, Nilsson J. Calcitonin gene-related peptide stimulates proliferation of human endothhelial cells. Proc Natl Acad Sci USA 87: 3299-3303, 1990.
11. Hansel DE, Eipper BA, Ronnett GV. Neuropeptide Y functions as a neuroproliferative factor. Nature 410: 940-944, 2001.
12. Heilig M, Widerlov E. Neurobiology and clinical aspects of neuropeptide Y. Crit Rev Neurobiol 9: 115-136, 1995.
13. Hirabayashi A, Nishiwaki K, Shimada Y, Ishikawa N. Role of neuropeptide Y and its receptor subtypes in neurogenic pulmonary edema. Eur J Pharmacol 296: 297-305, 1996.
14. Jiang WG, Martin TA, Matsumoto K, Nakamura T, Mansel RE. Hepatocyte growth factor/scatter factor decreases the expression of occluding and transendothelial resistance (TER) and increases paracellular permeability in human vascular endothelial cells. J Cell Physiol 181: 319-329, 1999.
15. Jiang X, Yang F, Tan H, Liao D, Bryan RM Jr, Randhawa JK, Rumbaut RE, Durante W, Schafer AI, Yang X, Wang H. Hyperhomocystinemia impairs endothelial function and eNOS activity via PKC activation. Arterioscler Thromb Vasc Biol 25: 2515-2521, 2005.
16. Kurimoto N, Nan YA, Chen ZY, Feng GG, Komatsu T, Kandatsu N, Ko J, Kawai N, Ishikawa N. Effects of specific signal transduction inhibitors on increased permeability across rat endothelial monolayers induced by neuropeptide Y or VEGF. Am J Physiol Heart Circ Physiol 287: H100-H106, 2004.
17. Larhammar D. Structural diversity of receptors for neuropeptide Y, peptide YY and pancreatic polypeptide. Regul Pept 65: 165-174, 1996.
18. Lee EW, Michalkiewicz M, Kitlinska J, Kalezic I, Switalska H, Yoo P, Sangkharat A, Ji H, Li L, Michalkiewicz T, Ljubisavljevic M, Johansson H, Grant DS, Zukowska Z. Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles. J Clin Invest 111: 1853-1862, 2003.
19. Michel MC, Beck-Sickinger A, Cox H, Doods HN, Herzog H, Larhammar D, Quirion R, Schwartz T, Westfall T. XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol Rev 50: 143-150, 1998.
20. 5 receptors. FASEB J 20: 1924-1926, 2006.
21. Mukhopadhyay D, Nagy JA, Manseau EJ, Dvorak HF. Vascular permeability factor/vascular endothelial growth factor-mediated signaling in mouse mesentery vascular endothelium. Cancer Res 58: 1278-1284, 1998.
22. Nan YS, Feng GG, Hotta Y, Nishiwaki K, Shimada Y, Ishikawa A, Kurimoto N, Ishikawa N. Neuropeptide Y enhances permeability across a rat aortic endothelial cell monolayer. Am J Physiol Heart Circ Physiol 286: H1027-H1033, 2004.
23. Nanka O, Valasek P, Dvorakova M, Grim M. Experimental hypoxia and embryonic angiogenesis. Dev Dyn 235: 723-733, 2006.
24. Pons J, Kitlinska J, Ji H, Lee EW, Zukowska Z. Mitogenic actions of neuropeptide Y in vascular smooth muscle cells: synergetic interactions with the beta-adrenergic system. Can J Physiol Pharmacol 81: 177-185, 2003.
25. Sakakibara H, Hashiba Y, Taki K, Kawanishi M, Shimada Y, Ishikawa N. Effects of sympathetic nerve stimulation on lung vascular permeability in the rat. Am Rev Respir Dis 145: 685-692, 1992.
26. Salvesen GS, Dixit VM. Caspase: intracellular signaling by proteolysis. Cell 91: 443-446, 1997.
27. Shine J, Potter EK, Biden T, Selbie LA, Herzog H. Neuropeptide Y and regulation of the cardiovascular system. J Hypertens Suppl 12: S41-S45, 1994.
28. Snedecor GW, Cochran WG. Statistical Methods. Ames, IA: Iowa State University Press, 1967.
29. Spyridopoulos I, Luedemann C, Chen D, Kearney M, Chen D, Murohara T, Principe N, Isner JM, Losordo DW. Divergence of angiogenic and vascular permeability signaling by VEGF: inhibition of protein kinase C suppresses VEGF-induced angiogenesis, but promotes VEGF-induced, NO-dependent vascular permeability. Arterioscler Thromb Vasc Biol 22: 901-906, 2002.
30. 2+ signalling. Pflügers Arch 438: 612-620, 1999.
31. Tatemoto K. Neuropeptide Y: complete amino acid sequence of the brain peptide. Proc Natl Acad Sci USA 79: 5485-5489, 1982.
32. Wise LM, Veikkola T, Mercer AA, Savory LJ, Fleming SB, Caesar C, Vitali A, Makinen T, Alitalo K, Stacker SA. Vascular endothelial growth factor (VEGF)-like protein from orf virus NZ2 binds to VEGFR2 and neuropilin-1. Proc Natl Acad Sci USA 96: 3071-3076, 1999.
33. 5-like receptors. Nat Med 3: 761-764, 1996.
34. Wu HM, Yuan Y, Zawieja DC, Tinsley J, Granger HJ. Role of phospholipase C, protein kinase C, and calcium in VEGF-induced venular hyperpermeability. Am J Physiol Heart Circ Physiol 276: H535-H542, 1999.
35. Zukowska Z, Karwatowska E, Rose W, Rone J, Movafagh S, Ji H, Yeh Y, Chen WT, Kleinman HK, Grouzmann E, Grant DS. Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium. Circ Res 83: 187-195, 1998.